Wednesday, June 15, 2011
It's Official: Antipsychotic Drugs Labelling Update
Health Canada has released a warning to Healthcare professionals and consumers regardng Antipsychotic drugs and the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy.
Now they tell us!
Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy.
Health Canada is informing healthcare professionals and consumers that the prescribing information for the entire class of antipsychotic drugs is being updated. The updated labelling will contain safety information on the potential risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers were treated with these drugs during the third trimester of their pregnancy.
So, if a child in its mother's womb can suffer withdrawal by proxy, just imagine what suffering the children throughout classrooms of the UK, Canada, America, Australia etc will have to endure.
Here's a list of some antipsychotic drugs that are causing severe withdrawal problems with children today. Will the regulators be doing anything to help the millions of children worldwide that are hooked on these?
aripiprazole - Abilify
clozapine - Clozaril
olanzapine - Zyprexa
quetiapine - Seroquel
risperidone - Risperdal
ziprasidone - Geodon
Do you wish to continue labelling children with psychiatric disorders just so drugs [such as the above] can be ingested by children?
Wake up world. It's fraud, pure and simple.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING
About the Author :
Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
Labels: Abilify, Clozaril, Drugging children, Fraud, Geodon, Health Canada, Newborns, Risperdal, seroquel, withdrawal, zyprexa